Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2551]
Articles [106]
Editorials [3]
Conferences [83]
elearning [20]
AACR 2017: Five year survival rates for nivolumab to treat relapsed NSCLC
AACR 2017: Five year survival rates for nivolumab to treat relapsed NSCLC
Drug combination shows benefit in RAS-driven cancers
Drug combination shows benefit in RAS-driven cancers
AACR 2017: Patients with deadly lung cancers responsive to immunotherapy beat standard odds of survival
AACR 2017: Patients with deadly lung cancers responsive to immunotherapy beat standard odds of survival
AACR 2017: HER2/3 influence neratinib response in basket clinical trial
AACR 2017: HER2/3 influence neratinib response in basket clinical trial
American cancer death rates continue to decline in latest annual report
American cancer death rates continue to decline in latest annual report
Osimertinib receives FDA approval for relapsed EGFR NSCLC
Osimertinib receives FDA approval for relapsed EGFR NSCLC
High doses of vitamin C to improve cancer treatment passes human safety trial
High doses of vitamin C to improve cancer treatment passes human safety trial
New research investigates relapsing lung cancer after targetted therapies
New research investigates relapsing lung cancer after targetted therapies
Study finds promise for innovations in liquid biopsies
Study finds promise for innovations in liquid biopsies
Radiotherapy risks much higher for smokers
Radiotherapy risks much higher for smokers

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation